Neurotrope Bioscience Announces Agreement with Worldwide Clinical Trials, to Conduct Ongoing Phase 2 Study of Bryostatin-1, Partially Funded by NIH, for Alzheimer's Disease

Stock Information for Neurotrope Inc.

Loading

Please wait while we load your information from QuoteMedia.